NCT05855109

Developing a Screening Tool for Interstitial Lung Disease in People With Rheumatoid Arthritis Using Risk Factors

A Prospective, Multi-national, Cross-sectional Study on a Risk-factor Guided Approach to Interstitial Lung Disease Screening in Patients With Rheumatoid Arthritis at Higher Risk for ILD Using High Resolution Computed Tomography

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 1,304 (actual)
• Sponsor: Boehringer Ingelheim · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The overall aim of the study is to develop and validate a Rheumatoid Arthritis-Interstitial Lung Disease (RA-ILD) clinical prediction model (screening tool) based on risk factors to guide screening for ILD in patients with RA using High Resolution Computed Tomography (HRCT).

Conditions

• Arthritis, Rheumatoid
• Lung Diseases, Interstitial

Timeline

• Start date: 2023-11-27
• Primary completion: 2025-06-19
• Completion: 2025-06-26
• First posted: 2023-05-11
• Last updated: 2025-11-12

Locations

28 sites across 6 countries: United States, France, Germany, Italy, Spain, United Kingdom